tiprankstipranks
Trending News
More News >
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
Germany Market

IGC Pharma (IGS1) Ratios

Compare
6 Followers

IGC Pharma Ratios

DE:IGS1's free cash flow for Q3 2025 was $0.40. For the 2025 fiscal year, DE:IGS1's free cash flow was decreased by $ and operating cash flow was $-7.31. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
1.58 3.41 6.19 9.93 9.12
Quick Ratio
0.93 2.01 4.74 7.62 6.94
Cash Ratio
0.51 1.68 4.29 6.14 3.73
Solvency Ratio
-4.79 -4.76 -4.74 -2.77 -3.25
Operating Cash Flow Ratio
-2.22 -3.71 -3.06 -4.56 -4.46
Short-Term Operating Cash Flow Coverage
0.00 0.00 -2.49K -35.53 -173.54
Net Current Asset Value
$ 1.12M$ 4.20M$ 12.17M$ 20.45M$ 15.31M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.02 0.03 0.02
Debt-to-Equity Ratio
0.05 0.03 0.02 0.03 0.02
Debt-to-Capital Ratio
0.05 0.03 0.02 0.03 0.02
Long-Term Debt-to-Capital Ratio
0.02 <0.01 <0.01 <0.01 0.00
Financial Leverage Ratio
1.35 1.15 1.12 1.09 1.09
Debt Service Coverage Ratio
0.00 0.00 -4.79K -27.68 -150.04
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 0.02 0.01
Net Debt to EBITDA
0.09 0.25 0.67 1.64 1.00
Profitability Margins
Gross Profit Margin
54.50%48.52%48.87%12.58%2.82%
EBIT Margin
-728.48%-1270.14%-3782.37%-971.49%-168.57%
EBITDA Margin
-681.12%-1198.02%-3722.17%-918.26%-165.03%
Operating Profit Margin
-728.48%-1270.14%-3886.15%-971.49%-168.57%
Pretax Profit Margin
-966.54%-1263.01%-3782.37%-981.18%-179.64%
Net Profit Margin
-966.54%-1255.87%-3678.59%-1000.00%-198.85%
Continuous Operations Profit Margin
-966.54%-1263.01%-3782.37%-981.18%-179.64%
Net Income Per EBT
100.00%99.44%97.26%101.92%110.69%
EBT Per EBIT
132.68%99.44%97.33%101.00%106.57%
Return on Assets (ROA)
-131.29%-66.60%-54.42%-25.04%-27.94%
Return on Equity (ROE)
-177.57%-76.73%-61.13%-27.38%-30.51%
Return on Capital Employed (ROCE)
-129.57%-75.73%-63.25%-26.04%-25.39%
Return on Invested Capital (ROIC)
-127.48%-74.65%-61.19%-26.30%-28.05%
Return on Tangible Assets
-156.89%-71.47%-56.35%-25.32%-28.18%
Earnings Yield
-46.42%-64.10%-30.79%-11.96%-41.84%
Efficiency Ratios
Receivables Turnover
34.49 8.51 3.18 5.13 30.62
Payables Turnover
0.79 0.88 0.21 1.65 5.19
Inventory Turnover
0.40 0.18 0.06 0.14 0.93
Fixed Asset Turnover
0.35 0.11 0.04 0.08 0.39
Asset Turnover
0.14 0.05 0.01 0.03 0.14
Working Capital Turnover Ratio
0.45 0.11 0.02 0.05 0.20
Cash Conversion Cycle
468.03 1.69K 4.73K 2.40K 333.20
Days of Sales Outstanding
10.58 42.87 114.92 71.13 11.92
Days of Inventory Outstanding
918.46 2.06K 6.38K 2.55K 391.57
Days of Payables Outstanding
461.02 412.47 1.76K 221.32 70.29
Operating Cycle
929.05 2.11K 6.49K 2.62K 403.49
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 -0.13 -0.15 -0.26 -0.22
Free Cash Flow Per Share
-0.10 -0.15 -0.16 -0.30 -0.33
CapEx Per Share
<0.01 0.01 0.01 0.04 0.11
Free Cash Flow to Operating Cash Flow
1.10 1.09 1.10 1.15 1.51
Dividend Paid and CapEx Coverage Ratio
-10.10 -11.38 -10.06 -6.78 -1.94
Capital Expenditure Coverage Ratio
-10.10 -11.38 -10.06 -6.78 -1.94
Operating Cash Flow Coverage Ratio
-15.07 -14.65 -15.29 -10.96 -16.22
Operating Cash Flow to Sales Ratio
-3.87 -7.74 -18.80 -12.03 -2.13
Free Cash Flow Yield
-20.40%-42.95%-17.29%-16.50%-67.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.15 -1.56 -3.25 -8.36 -2.39
Price-to-Sales (P/S) Ratio
20.82 19.59 119.49 83.65 4.75
Price-to-Book (P/B) Ratio
3.83 1.20 1.99 2.29 0.73
Price-to-Free Cash Flow (P/FCF) Ratio
-4.90 -2.33 -5.78 -6.06 -1.47
Price-to-Operating Cash Flow Ratio
-5.39 -2.53 -6.36 -6.96 -2.23
Price-to-Earnings Growth (PEG) Ratio
0.00 0.06 -0.09 0.00 -0.03
Price-to-Fair Value
3.83 1.20 1.99 2.29 0.73
Enterprise Value Multiple
-2.96 -1.39 -2.54 -7.46 -1.88
Enterprise Value
27.15M 15.13M 37.47M 61.55M 12.63M
EV to EBITDA
-2.96 -1.39 -2.54 -7.46 -1.88
EV to Sales
20.19 16.61 94.37 68.54 3.10
EV to Free Cash Flow
-4.75 -1.97 -4.57 -4.97 -0.96
EV to Operating Cash Flow
-5.22 -2.15 -5.02 -5.70 -1.46
Tangible Book Value Per Share
0.10 0.26 0.46 0.77 0.67
Shareholders’ Equity Per Share
0.12 0.28 0.48 0.78 0.67
Tax and Other Ratios
Effective Tax Rate
0.00 <0.01 0.03 -0.02 -0.11
Revenue Per Share
0.02 0.02 <0.01 0.02 0.10
Net Income Per Share
-0.22 -0.22 -0.29 -0.21 -0.21
Tax Burden
1.00 0.99 0.97 1.02 1.11
Interest Burden
1.33 0.99 1.00 1.01 1.07
Research & Development to Revenue
2.81 3.80 5.87 1.03 0.25
SG&A to Revenue
0.00 0.00 0.00 0.00 1.47
Stock-Based Compensation to Revenue
1.32 3.12 5.53 0.73 0.19
Income Quality
0.40 0.61 0.50 1.23 1.19
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis